Skip to main content
Careers Contact Us
FR
FR

Company

Who We Are Notre mission Our Leadership Our Global Presence Partnering

Science

Products Therapeutic Areas Pipeline Investigator-Initiated Research iWilson's Registry

Patient Resources

Rare Disease Education Patient-Centric Approach Patient Support Groups Safety Information

News & Events

News Events
Careers Contact Us
Company News · Video
mai 3, 2022

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™.

Explore Our Portfolio About Orphalan

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™ in this video:

Watch on YouTube

Healthcare Professionals

The page you are about to enter is intended for Healthcare Professionals. Please confirm that you are a Healthcare Professional.

Cancel